 |
|||
  |
|
||
 |
|||
|
|||
 |
|||
Amarin Corporation plc (NASDAQ ticker: AMRN)| www.amarincorp.com | is a biopharmaceutical company focused on improving the treatment of cardiovascular disease.
|
|||
 |
|||
Auspex Pharmaceuticals, Inc. | www.auspexpharma.com | is a developer of next-generation medicines with improved safety and performance and a pioneer in the targeted application of deuterium chemistry to clinically validated drugs.
|
|||
|
|
|||
Clarus Therapeutics, Inc. | www.clarustherapeutics.com | is developing new approaches for hormone replacement therapy. |
|||
 |
|||
NeuroTherapeutics Pharma, Inc. | www.ntprx.com | is focused on the development of novel therapeutics for the treatment of CNS disorders.
|
|||
|
|||
Ocera Therapeutics, Inc. | www.oceratherapeutics.com | is focused on the development of pharmaceutical products for gastrointestinal and liver diseases.
|
|||
 |
|||
Oriel Therapeutics, Inc. | www.orieltherapeutics.com | is a respiratory drug delivery company developing dry powder delivery systems for the treatment of asthma and COPD.
|
|||
|
|||
Quinnova Pharmaceuticals, Inc. | www.quinnova.com | is a specialty pharmaceutical company focused on the development and commercialization of prescription drug products based on innovative drug delivery platforms for the dermatology market. |
|||
|
|||
Solstice Neurosciences, Inc. | www.solsticeneuro.com | manufactures and markets Myobloc™, an FDA approved formulation of Botulinum Toxin type B, for the treatment of neurologically-induced muscle spasms.
|
|||
|
|||
| Zogenix, Inc. | www.zogenix.com | is a specialty pharmaceutical company focused on the development and commercialization of medicines to treat CNS disorders and pain, with an initial focus on SUMAVEL™ DosePro™, a needle-free migraine treatment. | |||
|
|
|
|
|
